search
Back to results

Intestinal Permeability in Preterm Infants (IPPI)

Primary Purpose

Prematurity, Intestinal Permeability

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Lactulose -rhamnose solution
Sponsored by
University of Maryland, Baltimore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Prematurity focused on measuring intestinal permeability, preterm infants, dual sugar test

Eligibility Criteria

undefined - 4 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • <5 days
  • Gestational age 24-32 weeks

Exclusion criteria:

  • Nonviable or planned withdrawal of care
  • Significant GI dysfunction (e.g. heme-positive stools, abdominal distension (girth >2 cm baseline), or bilious emesis/aspirates.
  • Triplet or higher order multiple
  • Severe asphyxia
  • Lethal chromosome abnormalities
  • Cyanotic congenital heart disease
  • Intestinal atresia or perforation
  • Abdominal wall defects
  • Known galactosemia or other galactose intolerance

Sites / Locations

  • University of Maryland Medical Center

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Lactulose - rhamnose solution

Arm Description

Preterm Infants age 24-32 weeks gestation

Outcomes

Primary Outcome Measures

Intestinal permeability
Intestinal Permeability measured by urinary excretion of orally administered lactulose/rhamnose (La/Rh ratio)

Secondary Outcome Measures

Stool alpha-1 antitrypsin
Stool alpha-1 antitrypsin concentrations
Stool microbiota relative abundance
Relative abundance (%) Clostridiales species
Clostridiales absolute copy number
absolute copy number of Clostridiales species/g stool

Full Information

First Posted
December 19, 2012
Last Updated
September 27, 2021
Sponsor
University of Maryland, Baltimore
search

1. Study Identification

Unique Protocol Identification Number
NCT01756040
Brief Title
Intestinal Permeability in Preterm Infants
Acronym
IPPI
Official Title
Gut Permeability in Very Low Birth Weight Infants
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
February 1, 2013 (Actual)
Primary Completion Date
August 31, 2021 (Actual)
Study Completion Date
August 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Necrotizing enterocolitis (NEC) is a life-threatening, gastrointestinal emergency characterized by increased intestinal permeability, affects approximately 7 to 10% of infants <1500 g birthweight, and typically occurs within 7 to 14 days of birth. Mortality is as high as 30-50%. Prematurity is the greatest risk factor for the development of NEC due to the physiological immaturity of the gastrointestinal tract and altered or abnormal gut microbiota. Several studies have demonstrated that the initiation of an intense systemic and local inflammatory cascade leads to intestinal necrosis. The human intestine is lined by a single layer of cells exquisitely responsive to multiple stimuli and is populated by a complex climax community of microbial partners. Under normal circumstances, these intestinal cells form a tight but selective barrier to "friends and foes": microbes and most environmental substances are held at bay, but nutrients are absorbed efficiently. Epithelial barrier integrity is itself dynamic and matures over time starting soon after birth, though the mechanisms regulating dynamic permeability are poorly understood. Low birth weight, prematurity, and early postnatal age are associated with a leaky gut. Although intestinal permeability is higher at birth in preterm than term infants, there is usually rapid maturation of the intestinal barrier over the first few days of life in both populations. The investigators hypothesize that increased levels of measures of intestinal permeability (serum zonulin, urine lactulose/rhamnose (LA/Rh), and fecal alpha1- antitrypsin will identify infants at high risk for NEC. The purpose of the study is to determine whether measurement of intestinal permeability in serum will correlate with other markers of intestinal barrier leakiness measured in urine (LA/Rh) and stool (alpha-1 antitrypsin. If there is good correlation, then zonulin or serum rhamnose may be a useful measure to identify preterm babies at risk for NEC.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prematurity, Intestinal Permeability
Keywords
intestinal permeability, preterm infants, dual sugar test

7. Study Design

Primary Purpose
Screening
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
214 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lactulose - rhamnose solution
Arm Type
Other
Arm Description
Preterm Infants age 24-32 weeks gestation
Intervention Type
Drug
Intervention Name(s)
Lactulose -rhamnose solution
Other Intervention Name(s)
dual sugar solution
Intervention Description
Measurement of intestinal permeability by use of mon- digestible sugars known not to cross the intestinal barrier in normal healthy intestinal tissue
Primary Outcome Measure Information:
Title
Intestinal permeability
Description
Intestinal Permeability measured by urinary excretion of orally administered lactulose/rhamnose (La/Rh ratio)
Time Frame
7 years
Secondary Outcome Measure Information:
Title
Stool alpha-1 antitrypsin
Description
Stool alpha-1 antitrypsin concentrations
Time Frame
7 years
Title
Stool microbiota relative abundance
Description
Relative abundance (%) Clostridiales species
Time Frame
7 years
Title
Clostridiales absolute copy number
Description
absolute copy number of Clostridiales species/g stool
Time Frame
7 years
Other Pre-specified Outcome Measures:
Title
Occurrence of Necrotizing enterocolitis
Description
Frequency of ≥ Stage 2 Necrotizing enterocolitis
Time Frame
7 years
Title
Duration of antibiotic exposure
Description
Number of days of antibiotic exposure
Time Frame
7 years
Title
Breastmilk feeding initiation
Description
Postnatal age when breast milk feeding initiated
Time Frame
7 years
Title
Postnatal age full feeds reached
Description
Postnatal age when all nutrition is provided by enteral feeds
Time Frame
7 years

10. Eligibility

Sex
All
Maximum Age & Unit of Time
4 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: <5 days Gestational age 24-32 weeks Exclusion criteria: Nonviable or planned withdrawal of care Significant GI dysfunction (e.g. heme-positive stools, abdominal distension (girth >2 cm baseline), or bilious emesis/aspirates. Triplet or higher order multiple Severe asphyxia Lethal chromosome abnormalities Cyanotic congenital heart disease Intestinal atresia or perforation Abdominal wall defects Known galactosemia or other galactose intolerance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alessio Fasano, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Rose M Viscardi, MD
Organizational Affiliation
University of Maryland, College Park
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Maryland Medical Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18832585
Citation
Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol. 2008 Nov;173(5):1243-52. doi: 10.2353/ajpath.2008.080192. Epub 2008 Oct 2.
Results Reference
background
PubMed Identifier
8125384
Citation
Bjarnason I. Intestinal permeability. Gut. 1994 Jan;35(1 Suppl):S18-22. doi: 10.1136/gut.35.1_suppl.s18.
Results Reference
background
PubMed Identifier
22888267
Citation
van Wijck K, Bessems BA, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K. Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose? Clin Exp Gastroenterol. 2012;5:139-50. doi: 10.2147/CEG.S31799. Epub 2012 Jul 19.
Results Reference
background
PubMed Identifier
22892368
Citation
van Wijck K, Verlinden TJ, van Eijk HM, Dekker J, Buurman WA, Dejong CH, Lenaerts K. Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: a randomized controlled crossover trial. Clin Nutr. 2013 Apr;32(2):245-51. doi: 10.1016/j.clnu.2012.06.014. Epub 2012 Aug 11.
Results Reference
background
PubMed Identifier
7065710
Citation
Beach RC, Menzies IS, Clayden GS, Scopes JW. Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child. 1982 Feb;57(2):141-5. doi: 10.1136/adc.57.2.141.
Results Reference
background
PubMed Identifier
11283883
Citation
Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? J Pediatr Surg. 2001 Apr;36(4):587-92. doi: 10.1053/jpsu.2001.22288.
Results Reference
background
PubMed Identifier
11756641
Citation
Rouwet EV, Heineman E, Buurman WA, ter Riet G, Ramsay G, Blanco CE. Intestinal permeability and carrier-mediated monosaccharide absorption in preterm neonates during the early postnatal period. Pediatr Res. 2002 Jan;51(1):64-70. doi: 10.1203/00006450-200201000-00012.
Results Reference
background
PubMed Identifier
15798461
Citation
Albers MJ, Steyerberg EW, Hazebroek FW, Mourik M, Borsboom GJ, Rietveld T, Huijmans JG, Tibboel D. Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial. Ann Surg. 2005 Apr;241(4):599-606. doi: 10.1097/01.sla.0000157270.24991.71.
Results Reference
background
PubMed Identifier
9473094
Citation
Piena M, Albers MJ, Van Haard PM, Gischler S, Tibboel D. Introduction of enteral feeding in neonates on extracorporeal membrane oxygenation after evaluation of intestinal permeability changes. J Pediatr Surg. 1998 Jan;33(1):30-4. doi: 10.1016/s0022-3468(98)90355-4.
Results Reference
background
PubMed Identifier
16148815
Citation
Malagon I, Onkenhout W, Klok M, van der Poel PF, Bovill JG, Hazekamp MG. Gut permeability in neonates after a stage 1 Norwood procedure. Pediatr Crit Care Med. 2005 Sep;6(5):547-9. doi: 10.1097/01.pcc.0000175990.72753.97.
Results Reference
background
PubMed Identifier
3089818
Citation
Noone C, Menzies IS, Banatvala JE, Scopes JW. Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest. 1986 Jun;16(3):217-25. doi: 10.1111/j.1365-2362.1986.tb01332.x.
Results Reference
background
PubMed Identifier
12496227
Citation
van Elburg RM, Fetter WP, Bunkers CM, Heymans HS. Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F52-5. doi: 10.1136/fn.88.1.f52.
Results Reference
background
PubMed Identifier
8583288
Citation
Catassi C, Bonucci A, Coppa GV, Carlucci A, Giorgi PL. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr. 1995 Nov;21(4):383-6. doi: 10.1097/00005176-199511000-00003.
Results Reference
background
PubMed Identifier
28159311
Citation
Saleem B, Okogbule-Wonodi AC, Fasano A, Magder LS, Ravel J, Kapoor S, Viscardi RM. Intestinal Barrier Maturation in Very Low Birthweight Infants: Relationship to Feeding and Antibiotic Exposure. J Pediatr. 2017 Apr;183:31-36.e1. doi: 10.1016/j.jpeds.2017.01.013. Epub 2017 Jan 31.
Results Reference
derived

Learn more about this trial

Intestinal Permeability in Preterm Infants

We'll reach out to this number within 24 hrs